scispace - formally typeset
J

Jamie Case

Researcher at Scripps Health

Publications -  73
Citations -  2864

Jamie Case is an academic researcher from Scripps Health. The author has contributed to research in topics: Progenitor cell & CD34. The author has an hindex of 22, co-authored 72 publications receiving 2703 citations. Previous affiliations of Jamie Case include Indiana University – Purdue University Indianapolis & Boston Children's Hospital.

Papers
More filters

Neurofibromin Deficient Myeloid Cells are Critical Mediators of Aneurysm Formation In Vivo

TL;DR: In this paper, the authors used an angiotensin II-induced aneurysm model to demonstrate that heterozygous inactivation of NF1 (Nf1+/−) enhanced vessel wall formation with myeloid cell infiltration and increased oxidative stress.
Journal ArticleDOI

Neurofibromin-Deficient Myeloid Cells Are Critical Mediators of Aneurysm Formation In Vivo

TL;DR: Genetic and pharmacological evidence is provided that Nf1+/– myeloid cells are the cellular triggers for aneurysm formation in a novel model of NF1 vasculopathy and provide a potential therapeutic target.
Journal ArticleDOI

Skeletal muscle-derived progenitor cells exhibit neural competence.

TL;DR: It is demonstrated that phenotypically homogenous skeletal muscle progenitor cells defined as Lin−CD45−CD117−CD90+ cells express neural stem cell markers and are responsive to neural induction signals.

Neurofibromin is a novel regulator of Ras-induced reactive oxygen species production in mice and humans

TL;DR: In this article, the authors used compound mutant and lineage-restricted mice to demonstrate that Nf1(+/-) macrophages produce excessive reactive oxygen species (ROS) and enhance smooth muscle cell proliferation in vitro and in vivo.